Zacks Investment Research
10 Mar 2026, 13:36 UTC · 28w ago
ADC Therapeutics SA (ADCT) Reports Q4 Loss, Tops Revenue Estimates
Verdict
Headline takes no side. We score ADCT +0.80 across four claims — strongly bullish.
- Expected · ADCT
+0.80strongly bullish
−1 bearish0bullish +1More positive than 88% of ticker scores this week
- Actual





